Comparative assessment of the therapeutic effects of the topical and systemic forms of Hypericum perforatum extract on induced oral mucositis in golden hamsters
- 1 October 2014
- journal article
- research article
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 43 (10) , 1286-1292
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich creamEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- Anti-Inflammatory Activity of Hyperoside Through the Suppression of Nuclear Factor-κB Activation in Mouse Peritoneal MacrophagesThe American Journal of Chinese Medicine, 2011
- Investigations on the in vivo wound healing potential of Hypericum perforatum L.Journal of Ethnopharmacology, 2010
- Inhibition of Prostaglandin E2 Production by Anti-inflammatory Hypericum perforatum Extracts and Constituents in RAW264.7 Mouse Macrophage CellsJournal of Agricultural and Food Chemistry, 2007
- Hyperforin Blocks Neutrophil Activation of Matrix Metalloproteinase-9, Motility and Recruitment, and Restrains Inflammation-Triggered Angiogenesis and Lung FibrosisThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Effects of the tumour necrosis factor‐α inhibitors pentoxifylline and thalidomide in short‐term experimental oral mucositis in hamstersEuropean Journal of Oral Sciences, 2005
- Chemotherapy‐ and Radiotherapy‐Induced Oral Mucositis: Review of Preventive Strategies and TreatmentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenaseBiochemical Pharmacology, 2002
- In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatumJournal of Pharmacy and Pharmacology, 2002
- An animal model for mucositis induced by cancer chemotherapyOral Surgery, Oral Medicine, Oral Pathology, 1990